Synergy Pharma (SGYP) IBS-C Risk Level Low, Outlook Solid; Aegis Boosts PT …
Synergy Pharma (SGYP) IBS-C Risk Level Low, Outlook Solid; Aegis Boosts PT …
We are expecting plecanatide to show similar efficacy to linaclotide, with a lower incidence and lesser severity of diarrhea as a side effect. Selvaraju thinks Syngery's pipeline is shaping -up favorably … Finally, Synergy is also studying the impact …
Read more on StreetInsider.com (subscription)
Matts Crohn’s: My year long painkiller experience, Codeine, Tramadol 23/12/2012 — My year long painkiller experience.
Related Side Effects Of Methadone Constipation Information…